Evaluating traditional phase 2 trial design of systemic therapies in recurrent/advanced cervical cancer: A NRG Oncology/Gynecologic Oncology Group (GOG) ancillary data study.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. e16592-e16592
Author(s):  
Lilian Tran Gien ◽  
Wei Deng ◽  
Gillian Thomas
Keyword(s):  
Cervical Cancer ◽  
Trial Design ◽  
Gynecologic Oncology ◽  
Gynecologic Oncology Group ◽  
Advanced Cervical Cancer ◽  
Phase 2 ◽  
Oncology Group ◽  
Ancillary Data ◽  
Phase 2 Trial ◽  
Systemic Therapies

Quality of life and survival in advanced cervical cancer: A Gynecologic Oncology Group study

2012 ◽  
Vol 125 (2) ◽  
pp. 315-319 ◽  
Author(s):  
Dana M. Chase ◽  
Helen Q. Huang ◽  
Lari Wenzel ◽  
David Cella ◽  
Richard McQuellon ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Cervical Cancer ◽  
Gynecologic Oncology ◽  
Gynecologic Oncology Group ◽  
Advanced Cervical Cancer ◽  
Oncology Group ◽  
Oncology Group Study

scholarly journals Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology—Gynecologic Oncology Group Study 240 (NCT 00803062)

2020 ◽  
Vol 19 (11) ◽  
pp. 2363-2370 ◽  
Author(s):  
Krishnansu S. Tewari ◽  
Michael W. Sill ◽  
Bradley J. Monk ◽  
Richard T. Penson ◽  
David H. Moore ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Tumor Cells ◽  
Circulating Tumor Cells ◽  
Gynecologic Oncology ◽  
Gynecologic Oncology Group ◽  
Advanced Cervical Cancer ◽  
Oncology Group ◽  
Oncology Group Study

scholarly journals Efficacy and safety of bevacizumab in recurrent sex cord-stromal ovarian tumors: Results of a phase 2 trial of the Gynecologic Oncology Group

Cancer ◽  
2013 ◽  
Vol 120 (3) ◽  
pp. 344-351 ◽  
Author(s):  
Jubilee Brown ◽  
William E. Brady ◽  
Julian Schink ◽  
Linda Van Le ◽  
Mario Leitao ◽  
...  
Keyword(s):  
Gynecologic Oncology ◽  
Ovarian Tumors ◽  
Gynecologic Oncology Group ◽  
Phase 2 ◽  
Efficacy And Safety ◽  
Oncology Group ◽  
Phase 2 Trial
Sign in / Sign up

Export Citation Format

Share Document